K Mac Syrup is a pharmaceutical formulation containing Magnesium Citrate (375 mg/5 ml) and Potassium Citrate (1100 mg/5 ml), designed to correct and prevent electrolyte imbalances, particularly hypomagnesemia and hypokalemia. Magnesium and potassium are essential electrolytes involved in numerous physiological processes, including neuromuscular function, cardiac rhythm regulation, and acid-base balance. This syrup is indicated for patients requiring supplementation due to deficiencies caused by conditions such as chronic diarrhea, diuretic therapy, or inadequate dietary intake. The citrate salts enhance bioavailability and contribute to urinary alkalinization, which may be beneficial in managing certain renal calculi and metabolic acidosis. K Mac Syrup should be administered orally, with dosage individualized based on serum electrolyte levels and clinical response. Caution is advised in patients with renal impairment, as accumulation of magnesium and potassium may lead to hypermagnesemia or hyperkalemia, potentially causing cardiac arrhythmias or neuromuscular disturbances. Monitoring of serum electrolytes is recommended during therapy. Adverse effects are generally mild but may include gastrointestinal discomfort such as nausea or diarrhea. K Mac Syrup is contraindicated in patients with hyperkalemia, hypermagnesemia, or hypersensitivity to any component of the formulation. It is essential to use this medication under medical supervision to ensure safe and effective correction of electrolyte disturbances.